Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000895421-26-000009·MORGAN STANLEY
Schedule 13G ownership disclosure
Ventyx Biosciences Inc
Common Stock · CUSIP: 92332V107
Event date: 2026-01-31
- Filing-level shares
- 237,358
- Percent of class
- 0.3%
- Morgan Stanley
Shares: 237,358 · Class: 0.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-26-000009
- Form type
- SCHEDULE 13G/A
- Filer
- MORGAN STANLEY
- CIK
- CIK 895421
- Filed
- Feb 06, 2026
- Reporting period
- Jan 31, 2026
- Description
- Schedule 13G beneficial ownership